Antibodies to glut4 no sc 79838

Manufactured by Santa Cruz Biotechnology

Sourced in United States

Antibodies to GLUT4 (no. sc-79838) are a laboratory reagent produced by Santa Cruz Biotechnology for use in research applications. The antibodies are designed to detect the GLUT4 protein, which is a glucose transporter involved in insulin-stimulated glucose uptake. The core function of these antibodies is to enable the identification and study of the GLUT4 protein in various experimental systems.

Automatically generated - may contain errors

Lab products found in correlation

Pparγ no ab45036, by Abcam (3 mentions) β actin no 4970, by Cell Signaling Technology (2 mentions) β actin, by Cell Signaling Technology (1 mentions)

Spelling variants of this product

GLUT4 (30 citations)

3 protocols using antibodies to glut4 no sc 79838

Western Blotting Antibody Sourcing

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antibodies to GLUT4 (no. sc-79838) were obtained from Santa Cruz Biotech (Santa Cruz, CA, USA). Phospho-AMPK (Thr¹⁷²), PPARα (no. ab8934), and PPARγ (no. ab45036) antibodies were purchased from Abcam Inc. (Cambridge, MA, USA). FAS (no. 3180), phospho-Akt (Ser⁴⁷³) (no. 4060), total AMPK (Thr¹⁷²), phospho-FoxO1 (Ser²⁵⁶) (no. 11115), total-FoxO1 (Ser²⁵⁶) (no. 2880), and β-actin (no. 4970) antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). Secondary anti-rabbit antibodies were purchased from Jackson ImmunoRes. Lab., Inc. (West Grove, PA, USA).

Lin C.H., Kuo Y.H, & Shih C.C. (2018). Antidiabetic and hypolipidemic activities of eburicoic acid, a triterpenoid compound from Antrodia camphorata, by regulation of Akt phosphorylation, gluconeogenesis, and PPARα in streptozotocin-induced diabetic mice. RSC Advances, 8(37), 20462-20476.

+ Open protocol

+ Expand

Western Blot Antibody Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antibodies to GLUT4 (no. sc-79838) were obtained from Santa Cruz Biotech (Santa Cruz, CA, USA). Phospho-AMPK (Thr¹⁷²), PPARα (no. ab8934), and PPARγ (no. ab45036) antibodies were purchased from Abcam Inc. (Cambridge, MA, USA). FAS (no. 3180), phospho-Akt (Ser⁴⁷³) (no. 4060), total AMPK (Thr¹⁷²), and β-actin (no. 4970) antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). Secondary anti-rabbit antibodies were purchased from Jackson ImmunoRes. Lab., Inc. (West Grove, PA, USA).

Kuo Y.H., Lin C.H, & Shih C.C. (2016). Dehydroeburicoic Acid from Antrodia camphorata Prevents the Diabetic and Dyslipidemic State via Modulation of Glucose Transporter 4, Peroxisome Proliferator-Activated Receptor α Expression and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice. International Journal of Molecular Sciences, 17(6), 872.

+ Open protocol

+ Expand

Antibody Sources for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antibodies to GLUT4 (no. sc-79838) were obtained from Santa Cruz Biotech (Santa Cruz, CA, USA), phospho-AMPK (Thr¹⁷²), PPARα (no. ab8934), and PPARγ (no. ab45036) were purchased from Abcam Inc. (Cambridge, MA, USA); FAS (no. 3180). Phospho-Akt (Ser⁴⁷³) (no. 4060), total AMPK (Thr¹⁷²), and β-actin (no. 4970) were obtained from Cell Signaling Technology (Danvers MA, USA). Secondary anti-rabbit antibodies were obtained from Jackson ImmunoRes. Lab., Inc. (West Grove, PA, USA).

Lin C.H., Wu J.B., Jian J.Y, & Shih C.C. (2017). (−)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice. PLoS ONE, 12(3), e0173984.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!